{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:09:31Z","timestamp":1777612171728,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000139","name":"U.S. EPA","doi-asserted-by":"publisher","award":["STAR RD83561202"],"award-info":[{"award-number":["STAR RD83561202"]}],"id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32 ES026005"],"award-info":[{"award-number":["F32 ES026005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007904","name":"Texas A&M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007904","name":"Texas A&M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.taap.2018.05.033","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T12:41:56Z","timestamp":1527597716000},"page":"142-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice"],"prefix":"10.1016","volume":"352","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0879-3098","authenticated-orcid":false,"given":"Chimeddulam","family":"Dalaijamts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Cichocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Syuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Rusyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihsueh A.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.05.033_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0090-9556(25)07243-5","article-title":"N-acetyl-S-(1,2,2-trichlorovinyl)-l-cysteine and 2,2,2-trichloroethanol: two novel metabolites of tetrachloroethene in humans after occupational exposure","volume":"24","author":"Birner","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2018.05.033_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s002040050284","article-title":"Population toxicokinetics of tetrachloroethylene","volume":"70","author":"Bois","year":"1996","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2018.05.033_bb0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/toxsci\/kfq362","article-title":"Interstrain differences in the liver effects of trichloroethylene in a multistrain panel of inbred mice","volume":"120","author":"Bradford","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.05.033_bb0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.etap.2004.12.026","article-title":"Developing an exposure\u2013dose\u2013response model for the acute neurotoxicity of organic solvents: overview and progress on in vitro models and dosimetry","volume":"19","author":"Bushnell","year":"2005","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0025","series-title":"National Health and Nutrition Examination Survey Data","author":"CDC","year":"2011"},{"key":"10.1016\/j.taap.2018.05.033_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.taap.2011.03.020","article-title":"Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans","volume":"253","author":"Chiu","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00335-017-9731-6","article-title":"Advancing chemical risk assessment decision-making with population variability data: challenges and opportunities","volume":"29","author":"Chiu","year":"2018","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.taap.2018.05.033_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfl129","article-title":"Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies","volume":"95","author":"Chiu","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.05.033_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2009.07.032","article-title":"Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach","volume":"241","author":"Chiu","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1289\/ehp.1307623","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of Interstrain variability in trichloroethylene metabolism in the mouse","volume":"122","author":"Chiu","year":"2014","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2018.05.033_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.14573\/altex.1608251","article-title":"A tiered, Bayesian approach to estimating population variability for regulatory decision-making","volume":"34","author":"Chiu","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.taap.2018.05.033_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/jpet.116.232629","article-title":"Target organ metabolism, toxicity, and mechanisms of trichloroethylene and Perchloroethylene: key similarities, differences, and data gaps","volume":"359","author":"Cichocki","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2018.05.033_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.116.238790","article-title":"Impact of nonalcoholic fatty liver disease on toxicokinetics of tetrachloroethylene in mice","volume":"361","author":"Cichocki","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2018.05.033_bb0070","doi-asserted-by":"crossref","DOI":"10.1289\/EHP788","article-title":"Characterization of variability in toxicokinetics and toxicodynamics of tetrachloroethylene using the collaborative cross mouse population","volume":"125","author":"Cichocki","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2018.05.033_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2006.06.008","article-title":"The use of Markov chain Monte Carlo uncertainty analysis to support a public health goal for perchloroethylene","volume":"47","author":"Covington","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jbt.2570010206","article-title":"Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine as a urinary metabolite of tetrachloroethylene: bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicity","volume":"1","author":"Dekant","year":"1986","journal-title":"J. Biochem. Toxicol."},{"key":"10.1016\/j.taap.2018.05.033_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/tx00003a008","article-title":"Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-l-cysteine and S-(1,2,2-trichlorovinyl)-l-cysteine formed by cysteine conjugate beta-lyase","volume":"1","author":"Dekant","year":"1988","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2018.05.033_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-2797(98)00077-5","article-title":"Glutathione conjugation of perchloroethene in subcellular fractions from rodent and human liver and kidney","volume":"116","author":"Dekant","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2018.05.033_bb0095","series-title":"Tissue Solubilities and Biotransformation Rates of Halocarbons: Experimental Determinations and Quantitative Modeling","author":"Gargas","year":"1988"},{"key":"10.1016\/j.taap.2018.05.033_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0041-008X(89)90137-3","article-title":"Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues","volume":"98","author":"Gargas","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4274(93)90126-I","article-title":"Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)","volume":"68","author":"Gearhart","year":"1993","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2018.05.033_bb0110","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/01621459.1996.10476708","article-title":"Physiological pharmacokinetic analysis using population modeling and informative prior distributions","volume":"91","author":"Gelman","year":"1996","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.taap.2018.05.033_bb0115","series-title":"Bayesian Data Analysis","author":"Gelman","year":"2004"},{"key":"10.1016\/j.taap.2018.05.033_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0041-008X(90)90264-U","article-title":"Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans","volume":"103","author":"Green","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0125","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(12)70485-0","article-title":"Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites","author":"Guha","year":"2012","journal-title":"The Lancet Oncology."},{"key":"10.1016\/j.taap.2018.05.033_bb0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1289\/ehp.1307359","article-title":"Human health effects of tetrachloroethylene: key findings and scientific issues","volume":"122","author":"Guyton","year":"2014","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2018.05.033_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yrtph.2006.05.012","article-title":"Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites","volume":"46","author":"Hack","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0140","doi-asserted-by":"crossref","DOI":"10.1289\/EHP1274","article-title":"New rodent population models may inform human health risk assessment and identification of genetic susceptibility to environmental exposures","volume":"125","author":"Harrill","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2018.05.033_bb0145","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Trichloroethylene, Tetrachloroethylene and Some Other Chlorinated Agents","volume":"Vol. 106","author":"IARC","year":"2014"},{"key":"10.1016\/j.taap.2018.05.033_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0031-6997(24)01491-1","article-title":"Hepatic and renal toxicities associated with perchloroethylene","volume":"53","author":"Lash","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2018.05.033_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/taap.1998.8402","article-title":"Glutathione conjugation of Perchloroethylene in rats and Micein vitro:sex-, species-, and tissue-dependent differences","volume":"150","author":"Lash","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3565(24)29523-9","article-title":"Renal and hepatic toxicity of trichloroethylene and its glutathione-derived metabolites in rats and mice: sex-, species-, and tissue-dependent differences","volume":"297","author":"Lash","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2018.05.033_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mrrev.2014.04.003","article-title":"Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity","volume":"762","author":"Lash","year":"2014","journal-title":"Mutation research. Reviews in mutation research"},{"key":"10.1016\/j.taap.2018.05.033_bb0170","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0090-9556(25)06742-X","article-title":"Species similarities and differences in pharmacokinetics","volume":"23","author":"Lin","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2018.05.033_bb0175","first-page":"1","author":"Luo","year":"2017","journal-title":"J. Toxic. Environ. Health A"},{"key":"10.1016\/j.taap.2018.05.033_bb0180","series-title":"(National Research Council) Science and Decisions: Advancing Risk Assessment","first-page":"422","author":"NRC","year":"2009"},{"key":"10.1016\/j.taap.2018.05.033_bb0185","series-title":"(National Research Council) Review of the Environmental Protection Agency's Draft IRIS Assessment of Tetrachloroethylene","author":"NRC","year":"2010"},{"key":"10.1016\/j.taap.2018.05.033_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0041-008X(88)90232-3","article-title":"The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat","volume":"92","author":"Odum","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/48.1.5","article-title":"Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation","volume":"48","author":"P\u00e4hler","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.05.033_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2006.12.018","article-title":"Impact of repeated exposure on toxicity of perchloroethylene in Swiss Webster mice","volume":"232","author":"Philip","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2018.05.033_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/taap.1996.0036","article-title":"In Vivoandin VitroStudies of Perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans","volume":"136","author":"Reitz","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0210","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2217\/pgs.10.100","article-title":"Toxicogenetics: population-based testing of drug and chemical safety in mouse models","volume":"11","author":"Rusyn","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.taap.2018.05.033_bb0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1289\/ehp.02110655","article-title":"Apartment residents' and day care workers' exposures to tetrachloroethylene and deficits in visual contrast sensitivity","volume":"110","author":"Schreiber","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2018.05.033_bb0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10590500701569430","article-title":"The application of non-default uncertainty factors in the U.S. EPA's integrated risk information system (IRIS). Part I: UF L, UF S, and \u201cother uncertainty factors\u201d","volume":"25","author":"Stedeford","year":"2007","journal-title":"Journal of Environmental Science and Health, Part C"},{"key":"10.1016\/j.taap.2018.05.033_bb0225","series-title":"EPA Names First Chemicals for Review Under New TSCA Legislation","author":"U.S. EPA","year":"2017"},{"key":"10.1016\/j.taap.2018.05.033_bb0235","series-title":"Toxicological Review of Tetrachloroethylene (CAS No. 127-18-4) in Support of Summary Information on the Integrated Risk Information System (IRIS)","author":"USEPA","year":"2011"},{"key":"10.1016\/j.taap.2018.05.033_bb0240","series-title":"Toxicological Review of Trichloroethylene (CAS No. 79-01-6) in Support of Summary Information on the Integrated Risk Information System (IRIS)","author":"USEPA","year":"2011"},{"key":"10.1016\/j.taap.2018.05.033_bb0245","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/toxsci\/kfx065","article-title":"Collaborative cross mouse population enables refinements to characterization of the variability in toxicokinetics of trichloroethylene and provides genetic evidence for the role of PPAR pathway in its oxidative metabolism","volume":"158","author":"Venkatratnam","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2018.05.033_bb0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/taap.1998.8548","article-title":"Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-l-cysteine in rats and humans after inhalation","volume":"153","author":"V\u00f6lkel","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.05.033_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1289\/ehp.1205687","article-title":"Addressing human variability in next-generation human health risk assessments of environmental chemicals","volume":"121","author":"Zeise","year":"2013","journal-title":"Environ. Health Perspect."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:45:11Z","timestamp":1758573911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18302436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"alternative-id":["S0041008X18302436"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.05.033","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}